| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -260.5% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 7.4 | n/a |
| Pr/Book | 0.8 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 35.1% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 1.52 | 5.71 | 6.65p | 8.7 | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 2.21 | 6.18 | 7.15p | 6.4 | 0.8 | +8% | n/a | 0.0% |
| 31-Dec-22 | 0.46 | 2.44 | 2.93p | 4.5 | n/a | -59% | n/a | 0.0% |
| 31-Dec-23 | 0.64 | (2.04) | (2.24)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 0.87 | (1.87) | (1.84)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Holding(s) in Company | 02-Jan-2026 | 07:00 | RNS |
| Holding(s) in Company | 02-Jan-2026 | 07:00 | RNS |
| SweetBiotix Overview and Update | 24-Nov-2025 | 07:00 | RNS |
| Holding(s) in Company | 02-Jan-2026 | ShareCast |
| Director dealings: Optibiotix Health finance dir... | 02-Oct-2025 | ShareCast |
| OptiBiotix inks distribution deal with weight ma... | 20-Aug-2025 | ShareCast |
| £5.7m float for weight-fighting OptiBiotix after... | 04-Aug-2014 | Express & Star |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 6.25p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 20.50 |
| 52 Week Low | 5.63 |
| Volume | 1,647,094 |
| Shares Issued | 103.30m |
| Market Cap | £6.46m |
| Beta | 0.36 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:13 | 800,000 @ 6.01p |
| 16:26 | 29,655 @ 6.39p |
| 16:09 | 15,358 @ 6.40p |
| 15:36 | 20,526 @ 6.12p |
| 14:04 | 12,500 @ 6.12p |
| CEO | Stephen O'Hara |
| Finance Director | David Blain |
You are here: research